/ 2 items

#GEHC↓

Featured/ GEHC/ 07/29/2026 · 12:25 PM

GE HealthCare Beats Q2 Estimates on Record Orders, Weighs Sale of Struggling Patient Care Unit

GE HealthCare posts record 11.1% order growth and $5.3B revenue in Q2 2026, beating estimates. Stock jumps as it reviews Patient Care unit sale.

Lantheus’ piflufolastat F18 (PYLARIFY in U.S. market)

LNTH/ 09/24/2025 · 2:29 PM

New Partnership Brings Leading Prostate Cancer Detection Tool to Japan

Lantheus licenses PYLARIFY, a leading PSMA PET imaging agent for prostate cancer, exclusively to GE HealthCare for development, manufacturing, and sales in Japan, a key international market.